Amniotic fluid proteome analysis from down syndrome pregnancies for biomarker discovery

Journal of Proteome Research

Volumn 9, Issue 7, 2010, Pages 3574-3582

  Cho, Chan Kyung J ^a,b   Smith, Christopher R ^c   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

amniotic fluid; APP; Down syndrome; hCG; prenatal screening; spectral counting; TNC

Indexed keywords

AMYLOID PRECURSOR PROTEIN; TENASCIN; BIOLOGICAL MARKER; PROTEOME;

ADULT; ALZHEIMER DISEASE; AMNION FLUID ANALYSIS; ARTICLE; COGNITIVE DEFECT; CONGENITAL DISORDER; CONTROLLED STUDY; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LEUKEMIA; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN ANALYSIS; AMNION FLUID; CHEMISTRY; CLUSTER ANALYSIS; FEMALE; GESTATIONAL AGE; METABOLISM; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AMNIOTIC FLUID; AMYLOID BETA-PROTEIN PRECURSOR; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; PROTEOME; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TENASCIN;

EID: 77954378406     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100088k     Document Type: Article

References (38)

1. Antonarakis, S. E.; Lyle, R.; Dermitzakis, E. T.; Reymond, A.; Deutsch, S. Chromosome 21 and down syndrome: from genomics to pathophysiology Nat. Rev. Genet. 2004, 5 (10) 725-38
2. Knight, G. J.; Palomaki, G. E.; Neveux, L. M.; Smith, D. E.; Kloza, E. M.; Pulkkinen, A. J.; Williams, J.; Haddow, J. E. Integrated serum screening for Down syndrome in primary obstetric practice Prenatal Diagn. 2005, 25 (12) 1162-7
3. Malone, F. D.; Canick, J. A.; Ball, R. H.; Nyberg, D. A.; Comstock, C. H.; Bukowski, R.; Berkowitz, R. L.; Gross, S. J.; Dugoff, L.; Craigo, S. D.; Timor-Tritsch, I. E.; Carr, S. R.; Wolfe, H. M.; Dukes, K.; Bianchi, D. W.; Rudnicka, A. R.; Hackshaw, A. K.; Lambert-Messerlian, G.; Wald, N. J.; D'Alton, M. E. First-trimester or second-trimester screening, or both, for Down's syndrome N. Engl. J. Med. 2005, 353 (19) 2001-11
4. Underwood, M. A.; Gilbert, W. M.; Sherman, M. P. Amniotic fluid: not just fetal urine anymore J. Perinatol. 2005, 25 (5) 341-8
5. Cho, C. K.; Shan, S. J.; Winsor, E. J.; Diamandis, E. P. Proteomics analysis of human amniotic fluid Mol. Cell. Proteomics 2007, 6 (8) 1406-15
6. Tsangaris, G. T.; Karamessinis, P.; Kolialexi, A.; Garbis, S. D.; Antsaklis, A.; Mavrou, A.; Fountoulakis, M. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome Proteomics 2006, 6 (15) 4410-9
7. Wang, T. H.; Chao, A. S.; Chen, J. K.; Chao, A.; Chang, Y. L.; Cheng, P. J.; Chang, S. D.; Wang, H. S. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes Fertil. Steril. 2009, 92 (1) 96-107
8. Kolialexi, A.; Tsangaris, G. T.; Papantoniou, N.; Anagnostopoulos, A. K.; Vougas, K.; Bagiokos, V.; Antsaklis, A.; Mavrou, A. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma Prenatal Diagn. 2008, 28 (8) 691-8
9. Nagalla, S. R.; Canick, J. A.; Jacob, T.; Schneider, K. A.; Reddy, A. P.; Thomas, A.; Dasari, S.; Lu, X.; Lapidus, J. A.; Lambert-Messerlian, G. M.; Gravett, M. G.; Roberts, C. T., Jr.; Luthy, D.; Malone, F. D.; D'Alton, M. E. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers J. Proteome Res. 2007, 6 (4) 1245-57
10. Cohen, E. D.; Ihida-Stansbury, K.; Lu, M. M.; Panettieri, R. A.; Jones, P. L.; Morrisey, E. E. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway J. Clin. Invest. 2009, 119 (9) 2538-49
11. Imanaka-Yoshida, K.; Matsumoto, K.; Hara, M.; Sakakura, T.; Yoshida, T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse Differentiation 2003, 71 (4-5) 291-8
12. Ishii, K.; Imanaka-Yoshida, K.; Yoshida, T.; Sugimura, Y. Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation Dev. Biol. 2008, 324 (2) 310-9
13. Papadopoulos, N.; Simopoulos, C.; Sigalas, J.; Kotini, A.; Cheva, A.; Tamiolakis, D. Induction of hepatic hematopoiesis with tenascin-C expression during the second trimester of development Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 113 (1) 56-60
14. Wald, N. J.; Watt, H. C.; Hackshaw, A. K. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters N. Engl. J. Med. 1999, 341 (7) 461-7
15. Wald, N. J.; Rodeck, C.; Hackshaw, A. K.; Walters, J.; Chitty, L.; Mackinson, A. M. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) J. Med. Screen. 2003, 10 (2) 56-104 (Pubitemid 36734906)
16. Dhallan, R.; Guo, X.; Emche, S.; Damewood, M.; Bayliss, P.; Cronin, M.; Barry, J.; Betz, J.; Franz, K.; Gold, K.; Vallecillo, B.; Varney, J. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study Lancet 2007, 369 (9560) 474-81
17. Lo, Y. M.; Tsui, N. B.; Chiu, R. W.; Lau, T. K.; Leung, T. N.; Heung, M. M.; Gerovassili, A.; Jin, Y.; Nicolaides, K. H.; Cantor, C. R.; Ding, C. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection Nat. Med. 2007, 13 (2) 218-23
18. Fan, H. C.; Blumenfeld, Y. J.; Chitkara, U.; Hudgins, L.; Quake, S. R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (42) 16266-71
19. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M.; Stable isotope labeling by amino acids in cell culture, SILAC as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1 (5) 376-86
20. Washburn, M. P.; Wolters, D.; Yates, J. R. 3rd, Large-scale analysis of the yeast proteome by multidimensional protein identification technology Nat. Biotechnol. 2001, 19 (3) 242-7
21. Ross, P. L.; Huang, Y. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents Mol. Cell. Proteomics 2004, 3 (12) 1154-69
22. Vogel, C.; Marcotte, E. M. Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data Nat. Protoc. 2008, 3 (9) 1444-51
23. Haddow, J. E.; Palomaki, G. E.; Knight, G. J.; Williams, J.; Pulkkinen, A.; Canick, J. A.; Saller, D. N., Jr.; Bowers, G. B. Prenatal screening for Down's syndrome with use of maternal serum markers N. Engl. J. Med. 1992, 327 (9) 588-93
24. Heyl, P. S.; Miller, W.; Canick, J. A. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol Obstet. Gynecol. 1990, 76 (6) 1025-31
25. Spencer, K.; Muller, F.; Aitken, D. A. Biochemical markers of trisomy 21 in amniotic fluid Prenatal Diagn. 1997, 17 (1) 31-7
26. Bogart, M. H.; Pandian, M. R.; Jones, O. W. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities Prenatal Diagn. 1987, 7 (9) 623-30
27. Iwatsubo, T.; Mann, D. M.; Odaka, A.; Suzuki, N.; Ihara, Y. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome Ann. Neurol. 1995, 37 (3) 294-9
28. Busciglio, J.; Pelsman, A.; Wong, C.; Pigino, G.; Yuan, M.; Mori, H.; Yankner, B. A. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome Neuron 2002, 33 (5) 677-88
29. Citron, M.; Vigo-Pelfrey, C.; Teplow, D. B.; Miller, C.; Schenk, D.; Johnston, J.; Winblad, B.; Venizelos, N.; Lannfelt, L.; Selkoe, D. J. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (25) 11993-7
30. Mullan, M.; Crawford, F.; Axelman, K.; Houlden, H.; Lilius, L.; Winblad, B.; Lannfelt, L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid Nat. Genet. 1992, 1 (5) 345-7
31. Mann, S. K.; Pinko, C.; Firtel, R. A. cAMP regulation of early gene expression in signal transduction mutants of Dictyostelium Dev. Biol. 1988, 130 (1) 294-303 (Pubitemid 19012707)
32. Chiquet-Ehrismann, R.; Kalla, P.; Pearson, C. A.; Beck, K.; Chiquet, M. Tenascin interferes with fibronectin action Cell 1988, 53 (3) 383-90
33. Mackie, E. J.; Tucker, R. P. The tenascin-C knockout revisited J. Cell Sci. 1999, 112 (Pt. 22) 3847-53
34. Slonim, D. K.; Koide, K.; Johnson, K. L.; Tantravahi, U.; Cowan, J. M.; Jarrah, Z.; Bianchi, D. W. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (23) 9425-9
35. Lejeune, J. Autosomal disorders Pediatrics 1963, 32, 326-37
36. Chung, I. H.; Lee, S. H.; Lee, K. W.; Park, S. H.; Cha, K. Y.; Kim, N. S.; Yoo, H. S.; Kim, Y. S.; Lee, S. Gene expression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray J. Korean Med. Sci. 2005, 20 (1) 82-7
37. Lockstone, H. E.; Harris, L. W.; Swatton, J. E.; Wayland, M. T.; Holland, A. J.; Bahn, S. Gene expression profiling in the adult Down syndrome brain Genomics 2007, 90 (6) 647-60
38. Olson, L. E.; Roper, R. J.; Baxter, L. L.; Carlson, E. J.; Epstein, C. J.; Reeves, R. H. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes Dev. Dyn. 2004, 230 (3) 581-9